TGFB1 and neoplasm: It has been observed that cytokines such as IL-2, IL-12, IL-15, IL-18, and TGF-β can modulate the anti-tumor immune response mediated by NK cells (97–103), offering new strategies and choices for immunotherapy by regulating the function and activity of NK cells.